CO Asbestos Abatement study materials
CO Asbestos Abatement study resources

CO Asbestos Abatement: Health effects of asbestos exposure

CO Asbestos Abatement · Work through your exam, one topic at a time.

All guide sections

Health effects of asbestos exposure

Domain 1 - Health effects of asbestos exposure

This domain tests the disease-specific facts the exam uses to evaluate exposure scenarios: which diseases asbestos causes, how dose and time interact, and why smoking changes the risk picture but not in the way many candidates assume.

The core disease set

  • Asbestosis is diffuse interstitial fibrosis from a high cumulative dose; it is not cancer, and it typically appears 10–20+ years after first exposure.
  • Lung cancer is the most common asbestos-related malignancy; risk rises with cumulative dose and is strongly synergistic with cigarette smoking, often modeled as multiplicative.
  • Mesothelioma is a malignancy of the pleura or peritoneum; latency is long, commonly 20–40+ years, and it can occur at relatively low doses. All commercial fiber types are associated with it, with amphiboles generally more potent.
  • Gastrointestinal cancer is associated with ingested fibers; the evidence is weaker than for lung cancer and mesothelioma, so exam questions usually treat it as a possible but less established outcome.
  • Other findings include pleural plaques and diffuse pleural thickening; plaques alone do not prove asbestosis.

Latency and dose

Latency is measured from first exposure, not last exposure. A short, intense exposure can still produce mesothelioma decades later. Asbestosis generally requires a much higher cumulative dose than mesothelioma.

Worked example

A 64-year-old retired pipefitter has pleural mesothelioma 32 years after his first asbestos job. He smoked for 20 years. The likely exam answer is that asbestos caused the mesothelioma; the 32-year interval fits mesothelioma latency; smoking does not cause mesothelioma, although it multiplies lung-cancer risk. Asbestosis is less likely without high-dose fibrosis findings. The reasoning is disease-specific: site, latency, and dose pattern.

Traps that cost marks

  • Measuring latency from the last exposure instead of the first.
  • Saying smoking causes mesothelioma; it does not.
  • Treating asbestosis as a cancer or as a low-dose disease.
  • Assuming a low-dose exposure cannot cause mesothelioma.
  • Giving GI cancer the same certainty as lung cancer.